Evolution, immune response, and cancer

Childhood acute lymphoblastic leukemia is triggered by the introduction of immunization against diphtheria

BACKGROUND

Childhood acute lymphoblastic leukemia has prenatal origin. Leukemogenic translocations originating during fetal life are insufficient for overt leukemia. Transgenic TEL-AML1 mice have failed to develop leukemia. Additional postnatal events are required for full leukemogenesis. The significant peak-age (2-5 years) first appeared after 1940 in Great Britain. Since then, childhood leukemia has almost unchangeable incidence. In 1940 the introduction of immunization against diphtheria on a national scale was begun in Great Britain.

HYPOTHESIS

Childhood acute lymphoblastic leukemia is triggered by vaccination against diphtheria.

TESTING THE HYPOTHESIS

Epidemiological survey for leukemia cases among "exemptors" and unvaccinated cases among ALL children should be done. Simultaneously, the transgenic TEL-AML1 mice should be vaccinated with the diphtheritic toxoid.

IMPLICATIONS OF THE HYPOTHESIS

If there is no leukemia among the "exemptors", no unvaccinated among ALL, and some mice develop leukemia upon vaccination childhood leukemia will be prevented by massive neonatal screening for leukemogenic genetics and/or with a new vaccination schedule.

Infection, immune responses and the aetiology of childhood leukaemia

Childhood leukaemia is the principal subtype of paediatric cancer and, despite success in treatment, its causes remain enigmatic. A plethora of candidate environmental exposures have been proposed, but most lack a biological rationale or consistent epidemiological evidence. Although there might not be a single or exclusive cause, an abnormal immune response to common infection(s) has emerged as a plausible aetiological mechanism.